Clinical Trials News

Medindia's Press Release’ section provides the latest press release on Clinical Trials from across the world for the global audience. This page links to 3936 Clinical Trials press releases.

Positive results from Phase II clinical trial (CGZ203 study) of Chiglitazar monotherapy for non-alcoholic steatohepatitis

SHENZHEN, China , March 18, 2024 /PRNewswire/ -- On March 18 2024, Shenzhen chipscreen biosciences Co., Ltd. (hereinafter referred to as "chipscreen biosciences", stock code: 688321. SH) announced that the Phase II clinical trial ...


myTomorrows Partners with The ALS Association to Support ALS Patients in Accessing Clinical Trials

Partnership with leading US-based ALS patient advocacy group furthers myTomorrows' mission of ensuring that patients confronting life-threatening diseases are aware of all possible treatment options NEW YORK , March 14, 2024 ...

NeuroGenesis Reports Positive Results from Phase 2 Extension Study in Progressive Multiple Sclerosis Treated with NG-01 Cell Therapy

 Data presented by the MS team at Hadassah Medical Center, Jerusalem , led by Prof. Dimitrios Karussis, in the Americas Committee for Treatment and Research in Multiple Sclerosis Forum reveal consistent reductions in serum levels of both NfL ...

BioCity Announces Enrollment Completion of the IgA Nephropathy (IgAN) Cohort in the Randomized, Placebo-controlled Phase II Clinical Trial of the ETA Receptor Antagonist SC0062

WUXI, China , Feb. 25, 2024 /PRNewswire/ -- BioCity Biopharma is pleased to announce the completion of enrollment of all 120 participants in the IgA nephropathy (IgAN) cohort in a randomized, double-blind, placebo-controlled Phase 2 ...

NouvNeu001 Achieves Milestone with Successful Dosing of First Patient, Signaling Smooth Progress in iRegene Therapeutics' Multicenter Clinical Trial for Innovative Novel Parkinson's Disease Therapy

WUHAN, China , Feb. 5, 2024 /PRNewswire/ -- iRegene Therapeutics Co., Ltd (iRegene) recently announced that NouvNeu001, the company's first innovative product, has completed the dosing for its first patient at Beijing Hospital, and the ...

Technoderma Medicines Phase 2 Clinical Trial of TDM-105795 Demonstrates Hair Growth in Androgenetic Alopecia

CHENGDU, China , Feb. 5, 2024 /PRNewswire/ -- Technoderma Medicines, Inc. ("the Company"), a clinical stage biopharmaceutical company, is pleased to report that the Company has completed its Phase 2a clinical trial (NCT05802173) of ...

Blue California Completes Groundbreaking Human Clinical Trial on Ergoactive® Ergothioneine Intervention for Cognitive Function, Memory, and Sleep

Rancho Santa Margarita, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Blue California , an industry leader in science-driven ingredient development, announced the successful completion of a groundbreaking human clinical trial of ergothioneine. A ...

Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients

Ibezapolstat outperformed vancomycin showing eradication of fecal C. difficile at Day 3 of treatment in 15 of 16 treated patients (94%), versus vancomycin which had eradication of C. difficile in 10 of 14 treated patients (71%). ...

APL-2301, a compound developed by Asieris for the treatment of Acinetobacter baumannii infection, was approved for Phase I clinical trials in Australia

SHANGHAI , Dec. 24, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors ...

Lynk Pharmaceuticals Announced First Rheumatoid Arthritis Patient Dosed in Phase ? Clinical Study of LNK01001

BOSTON and HANGZHOU and SHANGHAI, China , Dec. 20, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that it has dosed the first ...

Clinical Trials News »

UK Launches First Human Trial for Nipah Virus Vaccine

UK Launches First Human Trial for Nipah Virus Vaccine

Researchers at the University of Oxford in the UK have initiated the first human clinical trial to evaluate ChAdOx1 NipahB vaccine designed to safeguard individuals against the deadly Nipah virus . ( ) ChAdOx1 NipahB Vaccine Trial with 51 Participants to Combat Nipah Virus Threat Fifty-one people aged 18 to 55 will participate in the ...

Plant Chloroplasts Offer Hope for  Huntington's Disease Treatment

Plant Chloroplasts Offer Hope for Huntington's Disease Treatment

The stromal processing peptidase (SPP), a chloroplast plant enzyme, reduces the clumping of proteins that cause the pathogenic alterations in models of Huntingtons disease in human cells and the nematode Caenorhabditis elegans ( ). ...

‘Artificial Wombs’ In Human Trials Await FDA Approval

‘Artificial Wombs’ In Human Trials Await FDA Approval

A group of US researchers, who first conducted an ‘ artificial womb ’ experiment in lamb, are now seeking Food and Drug Administration (FDA) approval for its tests on humans ( ). This could potentially reduce deaths and disability for babies ...

Injecting Platelets Could be as Beneficial as Exercising to the Brain

Injecting Platelets Could be as Beneficial as Exercising to the Brain

The role of platelets in mediating the rejuvenating effects of exercise during physiological brain aging has been highlighted in a new study published in the journal Nature Communications . The University of Queensland researchers have found ...

Engineered Bacteria Offer New Hope for Early Cancer Detection

Engineered Bacteria Offer New Hope for Early Cancer Detection

Entering into a new era of advanced biological sensors, researchers have built bacteria that can detect cancer -related changes in human DNA. The innovation developed at the University of California San Diego in Australia has been successful in ...

More Clinical Trials News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.